Brief: Avicanna Enters Into A Multi-Faceted Strategic Manufacturing Agreement With Medipharm Labs

Medipharm Labs

14/05/2020 11:45

May 14 (Reuters) - Avicanna Inc  AVCN.TO :
    * AVICANNA SIGNS WIDE-RANGING STRATEGIC MANUFACTURING AND IP
LICENSING AGREEMENT WITH WORLD-CLASS CANADIAN MANUFACTURER
MEDIPHARM LABS
    * AVICANNA INC - ENTERED INTO A MULTI-FACETED STRATEGIC
MANUFACTURING AGREEMENT WITH MEDIPHARM LABS CORP
    * AVICANNA INC - PARTNERSHIP PROVIDES AVICANNA WITH A
COMMERCIAL
PATHWAY TO CANADIAN AND INTERNATIONAL SALES
    * AVICANNA INC - PARTNERSHIP PROVIDES CO WITH PHARMACEUTICAL
MANUFACTURING OF ITS PRODUCTS DESTINED FOR CLINICAL DEVELOPMENT
WITH ITS CANADIAN PARTNERS
    * AVICANNA - WILL GRANT MEDIPHARM LABS LICENSE TO USE CO'S
PROPRIETARY FORMULATIONS TO DEVELOP ADDITIONAL MEDIPHARM LABS &
WHITE LABEL BRANDED PRODUCTS

Source text for Eikon:  ID:nCNWZJ0yja 
Further company coverage:  AVCN.TO 

 (Reuters.Briefs@thomsonreuters.com)